On August 18, 2020, the United States filed a fraud lawsuit against Teva Pharmaceuticals USA, Inc., and Teva Neuroscience, Inc., the nation’s largest generic drug manufacturer. The United States accused Teva Pharmaceuticals of fraud, alleging it violated the Anti-Kickback Statute and False Claims Act by paying over $300 million to charities to cover Medicare co-pays for its drug, Copaxone, between 2006 and 2015. The government claimed this scheme generated false Medicare claims worth hundreds of millions of dollars while hiding the drug’s steep price increases.